MENU
PDSB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
PDS Biotechnology (PDSB) Earnings Date & Reports
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States... Show more
Industry: #Pharmaceuticals Major
A.I. Advisor
published Earnings
PDSB is expected to report earnings to rise 11.54% to -14 cents per share on August 18
Q2'26
Est.
$-0.14
Q1'26
Beat
by $0.02
Q4'25
Beat
by $0.05
Q3'25
Beat
by $0.02
Q2'25
Beat
by $0.01
The last earnings report on May 13 showed earnings per share of -12 cents, beating the estimate of -15 cents. With 230.41K shares outstanding, the current market capitalization sits at 51.92M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a developer of clinical-stage immunotherapies to treat various early-stage and late-stage cancers which includes head & neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer and related cancers
Industry Biotechnology
Profile
Details
Industry
Pharmaceuticals Major
Address
303A College Road
Phone
+1 800 208-3343
Employees
21
Web
https://www.pdsbiotech.com